Effects of Atorvastatin on Pressure Overload-induced Cardiac Hypertrophy Mediated by Calcineurin
Duan Yun-yan
Abstract
Duan Yun-yan
Abstract
To investigate the effects of atorvastatin on cardiac hypertrophy mediated by calcineurin in rats with pressure-overload,Sprague-Dawley rats were randomly allocated into three groups:The sham-operated groups(n=10),model groups(n=10) and atorvastatin-treated groups(n=10).The model of pressure overload was established by abdominal arota constriction.At the end of the treatment period,the left ventricular weight/body weight ratio,left ventricular mass,wall thickness(by echocardiography),myocardial content of CaN and CaNmRNA(by westernblot and RT-PCR) were assessed.It is resulted that ① The left ventricular weight/body weight ratio of model group,as well as atorvastatin-treated group,was significantly higher than sham-operated group(P0.05);compared with model group,the ratio was lower in atorvastatin-treated group(P0.05).② observed a higher level of CaN and CaNmRNA expression in model group,as well as atorvastatin-treated group,as compared to sham-operated group(P0.05);significant higher level of CaN and CaNmRNA expression was observed in model group compared to atorvastatin-treated group(P0.05).The present data suggests that atorvastatin may inhibit calcineurin-mediated hypertrophy in rats with pressure-overload.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To investigate the effects of atorvastatin on cardiac hypertrophy mediated by calcineurin in rats with pressure-overload,Sprague-Dawley rats were randomly allocated into three groups:The sham-operated groups(n=10),model groups(n=10) and atorvastatin-treated groups(n=10).The model of pressure overload was established by abdominal arota constriction.At the end of the treatment period,the left ventricular weight/body weight ratio,left ventricular mass,wall thickness(by echocardiography),myocardial content of CaN and CaNmRNA(by westernblot and RT-PCR) were assessed.It is resulted that ① The left ventricular weight/body weight ratio of model group,as well as atorvastatin-treated group,was significantly higher than sham-operated group(P0.05);compared with model group,the ratio was lower in atorvastatin-treated group(P0.05).② observed a higher level of CaN and CaNmRNA expression in model group,as well as atorvastatin-treated group,as compared to sham-operated group(P0.05);significant higher level of CaN and CaNmRNA expression was observed in model group compared to atorvastatin-treated group(P0.05).The present data suggests that atorvastatin may inhibit calcineurin-mediated hypertrophy in rats with pressure-overload.
Key concepts: Atorvastatin, Pressure overload, Calcineurin, Medicine, Rat model, Myocardial hypertrophy, Internal medicine, Muscle hypertrophy